Abstract
Introduction
Schizophrenia as one of the main indications for chronic antipsychotic treatment affects approximately 1 % of the population worldwide and manifests at young adult age. Besides the main side effects of antipsychotics such as extrapyramidal symptoms and metabolic adverse effects, many patients suffer from cardiovascular complications, particularly lengthened QT interval [1] . QT prolongation increases the risk of ventricular arrhythmias and eventually sudden cardiac death [2] .
Moreover, it was reported that also drug-free patients suffering from schizophrenia have an increased QT interval compared to age-matched healthy subjects [3] . It is supposed that the polymorphism in KCNH2 channel might be a possible connection between schizophrenia and QT prolongation. This channel is responsible for K + delayed rectifier potassium current and its blocking (e.g. pharmacological or by a variant in the channel gene) leads to a significant QT prolongation. Nevertheless, the mechanism connecting schizophrenia with QT prolongation has not been fully elucidated yet. Moreover, studying of the reasons of QT lengthening in schizophrenic patients is rather complicated due to their frequent comorbities and certain incapability to cooperate. The need of suitable model for such studies is apparent.
Therefore, the present study aimed to evaluate heart rate (HR) and QT interval duration in methylazoxymethanol acetate rat model of schizophrenia. Basic electrogram parameters were studied in isolated hearts of rats with schizophrenia-like phenotype under resting conditions and after haloperidol administration.
Methods
The study was carried out according to the recommendations of the European Community Guide for the Care and Use of Laboratory Animals and according to the experimental protocol approved by the Committee on the Protection of Animals, Faculty of Medicine, Masaryk University.
Experimental animals
On gestational day 17, time-mated female albino Sprague-Dawley rats were injected intraperitoneally with methylazoxymethanol acetate (MAM, Midwest Research Institute, Kansas City, USA; MAM group) or vehicle (saline; CON group), as previously described [4] . The offspring were weaned on the postnatal day 22 and housed in groups of two or three littermates under controlled environmental conditions (relative humidity 50-60%, temperature 23ºC ± 1ºC, inverted 12-hour lightdark cycle) with food and water available ab libitum.
Only male offspring were used in the study.
The offspring of MAM-treated females (MAM group) manifested schizophrenia-like phenotype, which was evaluated by set of standard behavioural tests in adulthood.
Isolated heart preparation
For isolated heart experiment, 32 weeks old rats with body mass 547 ± 68 g were used. Nine schizophrenia-like (MAM) and six control (CON) rats were deeply anaesthetised. The heart was rapidly excised from the thorax, placed in a cold (4°C) Krebs-Henseleit (K-H) solution and prepared for cannulation. The aorta was cannulated and the heart was perfused according to Langendorff at constant perfusion pressure (75 mmHg) with K-H solution (NaCl, 118 mM; NaHCO3, 27 mM; KCl, 4.8 mM; KH2PO4, 1.0 mM; MgSO4, 1.2 mM; CaCl2, 1.2 mM; glucose, 10 mM; 37°C; pH 7.4) aerated with 95% O2 and 5% CO2. The isolated heart was allowed to stabilize for 20 minutes. Immediately after stabilization, experimental protocol continued with two 40-minuteslasting consecutive phases: haloperidol exposure and washout with K-H solution. Haloperidol was administered diluted in K-H solution at the concentration of 10 nmol/L.
Data acquisition
Six Ag-AgCl electrodes placed in the inner surface of heart chamber were used for continual recording of electrogram in three orthogonal leads. Besides electrogram, the perfusion pressure and temperature of the perfusion solution were continuously monitored. All signals were recorded by an acquisition card NI USB-6229 BNC (National Instruments, TX, USA) with sampling frequency of 5 kHz and 12-bit resolution.
Data analyses
The whole processing was made in off-line mode using MATLAB R2014b (MathWorks, MA, USA). The positions of R peaks were detected by automatic detection method based on wavelet transform. HR was measured from the window of 10 consecutive RR intervals at the end of each experimental phase. In the same window, QT intervals were detected manually and corrected according to Bazett's formula.
Additionally, incidence of arrhythmias was assessed in electrograms. The total number of ventricular premature beats (VPBs) and supraventricular premature beats (SVPBs) was calculated for each experimental phase separately.
Basic descriptive statistic was then applied and results were expressed as mean ± SD. According to the results of Shapiro-Wilk test, calculated parameters are not normally distributed. Therefore, the non-parametric Mann-Whitney U test was used to test the differences between MAM and CON groups. Differences between data from consecutive phases were then verified using Wilcoxon signed-rank test. Spearman's rho was used to assess the correlation between numbers of pathological beats in consecutive experimental phases. For all above tests, p < 0.05 was considered significant.
Results

Heart rate
The values of HR are represented as box plots in Fig 1 . Slightly higher HR values were found in the MAM group in comparison with that of CON group in all experimental phases (270 ± 10 bpm in CON and 290 ± 31 bpm in MAM, respectively). However, no significant difference in HR between the groups was proven.
Administration of haloperidol as well as washout caused no significant changes of HR in either group (in comparison with HR measured in stabilization phase). 
QTc interval
Distribution of QTc values calculated in MAM and CON groups at the end of each experimental phase and results of statistical tests are presented in Fig. 2 . It is obvious that MAM hearts have significantly longer QTc interval than CON at the end of stabilization (64.8 ± 1.9 ms in CON and 69.5 ± 4.8 ms in MAM, respectively; p<0.05). This difference was even more significant during haloperidol administration because of increase of QTc in MAM and no change of QTc in CON group (63.2 ± 2.5 ms in CON and 72.7 ± 5.4 ms in MAM, respectively; p<0.01). The parameter values remain significantly different in washout, too.
Due to high dispersion of the values, increase of QTc during haloperidol administration in MAM group was not significant. During washout, QTc in MAM was decreased at the level of stabilization value, while in CON was stable. 
Incidence of arrhythmias
VPBs were observed in electrograms of both groups only sporadically, except of two experiments from MAM group, where total number of VPBs in washout reached 5 and 48, respectively.
Percentage distribution of SVPBs through the whole experiments within particular group is shown in Fig. 3 . It is evident that the character of distribution is the same in both groups.
If both groups are analysed together, than more than 1 SVPB were found in 13%, 67% and 80% of total number of experiments in stabilization, haloperidol administration and washout, respectively. More than 10 SVPBs were observed in 20% and 33 % of experiments in the second and last experimental phase, respectively. Significant positive correlation (Spearman's rho = 0.74, p<0.005) was obtained between total number of SVPBs during haloperidol administration and washout.
There is no difference in total number of SVPBs between MAM and CON groups, as can be seen in Fig. 4 . Number of SVPBs in MAM increases significantly during haloperidol administration and washout in comparison with corresponding previous phases. 
Discussion
Based on the neurodevelopmental hypothesis of schizophrenia, it becomes increasingly applicable that an injection of the MAM in pregnant rat dams at gestational day 17 produces long lasting behavioral (i.e. sensorimotor gating deficits, hyper-locomotion, social behavior impairment, and cognitive deficits) and molecular (i.e.: dysregulation of dopaminergic, glutamatergic and GABAergic neurotransmission) changes in the offspring. These changes are consistent with those observed in schizophrenic patients [5] .
According to the present data, MAM rats exhibit longer QT interval than controls. Moreover, QT prolongation is increased after administration of classical antipsychotic drug haloperidol.
One of the possible mechanisms of QT prolongation in schizophrenia-like rats might be the existence of variant polymorphism or mutation in gene for KCNH2 potassium channel [3] or in other genes (e.g. hERG gene) related to potassium channels and their regulation. Other mechanisms might be associated with alteration of dopamine D2 receptor signalling in the heart or with imbalance of autonomic nervous system, particularly with reduced efferent vagal activity [6] leading to abnormalities in heart rate variability [7] .
Some of the abovementioned mechanisms may be common also for antipsychotic action. It has been repeatedly reported that antipsychotics affect hERG gene, which was set as a link between inherited and acquired QT prolongation [8] . Moreover, antipsychotics such as haloperidol have affinity to various receptor systems and may affect heart functions directly. The main effectiveness of antipsychotics against positive symptoms of schizophrenia lies in the pharmacological blockade of D2 receptors in the dopamine pathways of the brain. These receptors' signaling pathway includes inositol 1,4,5-trisphosphate receptors; thus, calcium concentration both in endoplasmic reticulum and cytosol can be altered [9] . Dopamine D2 receptors are also present in the heart. Therefore it might be presumed that antipsychotic treatment affects calcium handling in the cardiac cells. This may lead to changes of electric activity of the heart. Still, the description of precise mechanisms of QT prolongation associated with schizophrenia and antipsychotic treatment need further investigation. Research on the highly translational neurodevelopmental MAM rat model of schizophrenia can bring new insights into these mechanisms.
